Connect with us

Hi, what are you looking for?

Tuesday, Jul 29, 2025
Mugglehead Investment Magazine
Alternative investment news based in Vancouver, B.C.
Alberta gov invests C$2M for continuation of provincial lung cancer screening program
Alberta gov invests C$2M for continuation of provincial lung cancer screening program
Image credit: Canadian Partnership Against Cancer

Medical and Pharmaceutical

Alberta invests C$2M for continuation of provincial lung cancer screening program

The Alberta Cancer Foundation is also contributing C$500K

The Government of Alberta has agreed to put another C$2 million into the province’s lung cancer screening program. The pilot initiative was first launched in 2022 with the aim of reaching residents in remote, rural and Indigenous communities.

Alongside the government funding announced on Friday, the Alberta Cancer Foundation (ACF) has agreed to spend half a million on the program’s continuation. Alberta currently lacks a permanent screening program for lung cancer like it has for colon, breast or cervical cancer despite the fact that the respiratory disease kills more people than those three combined.

The news follows Alberta’s government regulators investing C$1.5 million into mobile lung cancer screening trucks last September to augment the provincial program. The sum was matched by the ACF, enabling an aggregate contribution of C$3 million.

This non-profit charity is also known for funding an extensive lung cancer screening study completed in the province between 2014-2020 with 800 subjects.

To date, Alberta’s screening campaign has assessed more than 3,800 eligible patients and detected a significant number of cases in their early stages with low-dose CT scan machines.

“We welcome the Alberta government’s new investment to extend the #LungCancerScreening program for another year while work moves forward to make the program permanent,” commented Lung Cancer Canada — another charitable organization.

“We’ll keep pushing for equitable screening across the country, but today we celebrate the important momentum in AB!” 

Read more: Breath Diagnostics now offering a compelling investment opportunity

About 2,700 Albertans will be diagnosed with the disease throughout 2025.

The overall five-year survival rate for those in the province is about 28 per cent, highlighting the need for improvements to the current screening regimen.

“We’re making progress, with more people in Alberta surviving lung cancer than ever before, but more work remains,” Alberta’s health minister, Adriana LaGrange, said in a government news release.

Read more: Breath Diagnostics gives the public the chance to join the fight against cancer

 

Follow Mugglehead on X

Like Mugglehead on Facebook

Follow Rowan Dunne on X

Follow Rowan Dunne on LinkedIn

rowan@mugglehead.com

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Medical and Pharmaceutical

Artificial intelligence has the power to cut healthcare costs associated with lung cancer screening in half, he highlighted

Medical and Pharmaceutical

The White Ribbon Project aims to draw attention to how anyone can be diagnosed with the condition

Medical and Pharmaceutical

The CyPath Lung screening tool is also patented in China, Australia and Japan

Medical and Pharmaceutical

Medpace delivered a standout Q2, with revenue rising 14.2 per cent year-over-year to USD$603.3 million